Porth's Essentials of Pathophysiology, 4e
654
Kidney and Urinary Tract Function
U N I T 7
3. Martin RK. Acute kidney injury. AACN Adv Crit Care. 2010;21(6):350–356. 4. Belloma R, Kellum JA, Ranco C. Acute kidney injury. Lancet. 2012;380:756–766. 5. Khalil P, Murty P, Palevsky PM. The patient with acute renal injury. Prim Care. 2008;35:239–264. 6. Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol. 2011;22:999–1006. 7. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357(8):797–805. 8. Hall JE. Guyton and Hall Textbook of Medical Physiology . 12th ed. Philadelphia, PA: Saunders Elsevier; 2011:399–410. 9. Jennette JC. The kidney. In: Rubin R, Strayer DS. eds. Rubin’s Pathology: Clinicopathologic Basis for Medical Practice . 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012:791–794. 10. Alpers CE. The kidney. In: Kumar V, Abbas AK, Fausto N, eds. Robbins and Cotran Pathologic Basis of Disease . 8th ed. Philadelphia, PA: Saunders Elsevier; 2010:935–938. 11. McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin. 2005;21:261–280. 12. Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med. 2012;367(26):2505–2514. 13. Chonchol M, Chan L. Chronic kidney disease: manifestations and pathogenesis. In: Schrier RW, ed. Renal and Electrolyte Disorders . 7th ed. Philadelphia, PA: Wolters Kluwer Health/ Lippincott Williams & Wilkins; 2010:389–425. 14. Levey AS. Chronic kidney disease. Lancet. 2012;379:165–180. 15. Murphree DD, Thelen SM. Chronic kidney disease in primary care. J Am Board Fam Med. 2010;23(4):542–550. 16. Baumgarten M, Gehr T. Chronic kidney disease: detection and evaluation. Am Fam Physician. 2011;84(10):1138–1148. 17. National Kidney Foundation. Chronic kidney disease—a growing problems. 2013. Available at: http://www.kidney.org/news/ factsheets/CKD-A-Growing problem. Accessed July 4, 2013. 18. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. 2002. Available at: http://www.kidney.org/professionals/KDOQI/ guidelines_ckd/toc.htm. Accessed July 30, 2013. 19. Levey AS, Eckardt KW, Tsukamato Y. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089–2100. 20. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–2483. 21. Eknoyan G, Hostetter T, Barkis GL, et al. Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis. 2003;42:617–622. 22. Aimeras C, Argilés Á. The general picture of uremia. Semin Dial. 2009;22(4):329–333. 23. Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008;35:329–344. 24. Watnick S, Dirkx T. Kidney disease. In: Papadakis MA, McPhee SJ, eds. Current Medical Diagnosis and Treatment . New York, NY: McGraw-Hill Lange; 2013:908–917. 25. Tsimihodimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol. 2008;28:958–973. 26. Schiffrin EL, Lipman ML, Mann JFE. Chronic kidney disease: effects on cardiovascular function. Circulation. 2007;116:85–97. 27. Eknoyan G, Levin NW. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(suppl 3):S1–S201. 28. National Kidney Foundation Inc. KDOQI clinical practice guideline for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(suppl 3):S1–S202.
R E V I EW E X E R C I S E S
1. A 55-year-old man with diabetes and coronary heart disease, who had undergone cardiac catheterization with the use of a radiocontrast agent 2 days ago, is admitted to the emergency department with a flulike syndrome including chills, nausea, vomiting, abdominal pain, fatigue, and pulmonary congestion. His serum creatinine is elevated, and he has protein in his urine. He is admitted to the intensive care unit with a tentative diagnosis of acute kidney injury due to radiocontrast nephropathy. A. Radiocontrast agents are thought to exert their effects through decreased renal perfusion and through direct toxic effects on renal tubular structures. Explain how each of these phenomena contributes to the development of acute kidney injury. B. Explain the elevated serum creatinine, proteinuria, and presence of pulmonary congestion. 2. A 35-year-old, 70-kg white man with diabetes mellitus is seen in the diabetic clinic for his 6-month check-up. His serum creatinine, which was slightly elevated at his last visit, is now 1.6 mg/dL. A. Use the following website to estimate his GFR: http://www.kidney.org/professionals/kdoqi/ gfr_calculator.cfm B. Would he be classified as having chronic kidney disease? If so, what stage? What might be done to delay or prevent further deterioration of his kidney function? 3. Chronic kidney disease is accompanied by hyperphosphatemia, hypocalcemia, impaired activation of vitamin D, hyperparathyroidism, and skeletal complications. A. Explain the impaired activation of vitamin D and its consequences on calcium and phosphate homeostasis, parathyroid function, and mineralization of bone in persons with CKD. B. Explain the possible complications of the administration of activated forms of vitamin D on parathyroid function and calcium and phosphate homeostasis. R E F E R E N C E S 1. Rahman M, Shad F, Smith MC. Acute renal injury: a guide to diagnosis and management. Am Fam Physician. 2012;86(7):631–639. 2. Kellum JA, Lameire N; for the KDIGO Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204, 1–15.
Made with FlippingBook